Law360, New York (November 04, 2009) -- Germany-based Bayer CropScience AG has completed its $365 million acquisition of biotechnology company Athenix Corp., a portfolio company of private equity firm Boston Millennia Partners.
Bayer CropScience said Monday that it had bought Athenix for $365 million, with further cash payments of up to $35 million to be paid based on the achievement of certain...
